This is/was a big fish, and needed patients. They
Post# of 148172
They were flipping to reduce cost maybe %5 and keep setting target expected low prices. For the same reason, a %30 or %40 jump would be a huge victory. As I see, NOT visionary individuals with ability see a far distance, having some risk tolerance.
If they didn't sell at .30 they would have sold on the jump to .4x and still miss. So, it was just a matter of time in a uptrend for them to get out.
There are many stocks out there with which to make a few percent. So, they can recover any loss.
Loading/getting-back this is a huge mistake for them. If it drops 30%, they will sell again. This kinda stock needs a different level of risk appetite.
Now, they don't need to worry and keep calculating the upper bound. So, it's a win for them as well.
We can move on, back to caring about our own pocket and making some real money.
I think based on the price movement, we should see some exercising their options, and corp needing less money to raise. I'm thinking expecting $1.35 to $3 in the months, is quite reasonable, just by expecting a NASH partnership catalyst, Cancer BTD and more surprises.
GLTA